Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

ClinicalTrials.gov ID: NCT00084214

Public ClinicalTrials.gov record NCT00084214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-Stage Trial of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Metastatic Melanoma

Study identification

NCT ID
NCT00084214
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Synta Pharmaceuticals Corp.
Industry
Enrollment
103 participants

Conditions and interventions

Conditions

Interventions

  • STA-4783 Drug
  • Paclitaxel Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2004
Primary completion
Not listed
Completion
Not listed
Last update posted
Mar 5, 2014

Started 2004

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Genesis Cancer Center Hot Springs Arkansas 71913
Univ Of Arkansas/Arkansas Research Center Little Rock Arkansas 72205-7101
Scripps Cancer Center San Diego California 92121
Northern California Melanoma Center San Francisco California 94109
Cancer Institute Medical Group, Inc Santa Monica California 90404
Anschutz Cancer Pavillion - Univ Of Colorado Aurora Colorado 80010
Hematology Oncology P.C. Stamford Connecticut 06902-3628
Medical Oncology and Hematology, P.C. Waterbury Connecticut 06708
Emory University - Winship Cancer Institute Atlanta Georgia 30322-1013
Research Institute Hawaii Pacific Health Honolulu Hawaii 96813
Joliet Oncology-Hematology Associates, Ltd. Joliet Illinois 60435
Oncology Specialists Park Ridge Illinois 60068
Cancer Care Center Of Southern Indiana Bloomington Indiana 47403
Center For Cancer Care At Goshen Health Goshen Indiana 46527-0139
Indiana Oncology Hematology Consultants Iindianapolis Indiana 46202
Cancer Care Center New Albany Indiana 47150-6809
James Graham Brown Cancer Center - University Of Louisville Louisville Kentucky 40202
Maine Center for Cancer Medicine & Blood Disorders Scarborough Maine 04074
Hubert H. Humphrey Cancer Center Robbinsdale Minnesota 55422
Ellis Fischels Cancer Center - Univ Of Missouri Columbia Missouri 65203
Mountainside Hospital, Suburban Surgical Associates St Louis Missouri 63131
Piedmont Oncology Specialists Charlotte North Carolina 28207
Odyssey Research and St. Alexius Medical Center Bismarck North Dakota 58501
Providence Cancer Center Portland Oregon 97213-2933
Danville Hematology & Oncology, Inc. Danville Virginia 24541-4155
Office of James Stark, MD Portsmouth Virginia 23707
Virginia Cancer Institute Richmond Virginia 23230
University of Wisconsin Medical School Madison Wisconsin 53792-0001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00084214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00084214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →